DUVYZAT

What this means for you

Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98454709

Registration number

8111843

Mark type

Design + words

Filed

18 Mar 2024

Published for opposition

12 Nov 2024

Registered

20 Jan 2026

Attorney of record

John Pickerill

Goods and services

• Class 005 — Pharmaceuticals: Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders

Owner

• ITALFARMACO S.P.A., Milano, IT
• ITALFARMACO S.P.A., Milano, IT
• ITALFARMACO S.P.A., Milano, IT

Prosecution history

• 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
• 29 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 29 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 27 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
• 24 Jun 2025 — USE AMENDMENT FILED
• 26 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 24 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
• 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 12 Nov 2024 — PUBLISHED FOR OPPOSITION
• 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 02 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE